在乌干达使用Med Safety应用程序报告药物不良反应:一个集群随机对照试验
Ronald Kiguba1, Helen B Ndagije2, Norah Mwebaza1
1Department of Pharmacology and Therapeutics, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.
The Lancet. Global health
|September 20, 2025
概括
医疗安全应用程序显著增加了乌干达医疗保健工作者报告的药物不良反应 (ADR). 这个数字工具增强了低收入和中等收入国家 (LMICs) 的药物安全监测.
科学领域:
- 药物监督 药物监督 药物监督
- 数字卫生技术数字卫生技术
- 在LMICs的公共卫生.
背景情况:
- 在低收入和中等收入国家 (LMICs) 中药物的广泛使用需要有效的药物监管系统.
- 数字技术为改善药物安全监测提供了潜在的解决方案.
- 在乌干达,Med Safety应用程序被评估其提高药物不良反应 (ADR) 报告的有效性.
研究的目的:
- 评估Med Safety应用程序在改善医疗保健工作者报告ADR方面的有效性.
- 评估数字药监工具在资源有限的环境中的影响.
主要方法:
- 在乌干达的卫生设施中进行了一项务实,多中心,集群随机对照试验.
- 医疗保健工作人员接受了关于Med Safety应用程序和传统ADR报告方法 (干预) 或仅使用传统方法 (控制) 的培训.
- 主要结果是集群级别的ADR报告率,使用发病率比率进行分析.
主要成果:
- 使用Med Safety应用程序的干预组显示,与控制组相比,使用Med Safety应用程序的干预组显示,与控制组相比,ADR报告率的平均值显著更高 (每10万人/月有10.6个报告),每10万人/月有5.9个报告.
- 报告ADR的发病率比为1.73 (95%CI为1.26-2.37;p=0.001),表明干预组报告增加了73%.
- 该研究包括367个集群和2464名医疗保健工作者,平均随访时间为37.8个月.
结论:
- 医疗安全应用程序有效地提高了乌干达医疗保健工作者中ADR报告率.
- 将数字技术整合到药物监管系统中可以加强乌干达和其他低,中等收入国家 (LMIC) 的药物安全监测.
- 这些发现支持在资源有限的环境中更广泛地采用数字健康解决方案来监测药品安全.
相关概念视频
01:19Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
01:29Therapeutic Drug Monitoring: Affecting Factors
202
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
202
01:12Hazard Ratio
561
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
561
01:25Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K